During the past decade, University of Louisville Research Foundation conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Louisville Research Foundation" #1 sponsor was "Genzyme, a Sanofi Company" with 2 trials, followed by "Abbott Nutrition" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored, "CSL Behring" with 1 trials sponsored and "Chiesi Farmaceutici S.p.A." with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Louisville Research Foundation" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Arkansas Children's Hospital Research Institute" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "EKOS Corporation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "University of Louisville Research Foundation" are "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Antibody-mediated Rejection" (1 trials), "Blood Pressure" (1 trials), "Breast Cancer" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "University of Louisville Research Foundation" in a lesser frequency.

Most popular intervention types in "University of Louisville Research Foundation" are "Drug" (9 trials), "Biological" (4 trials), "Device" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Interferon beta-1a" (2 trials), "Placebo" (2 trials), "Acthar Gel" (1 trials), "Alemtuzumab" (1 trials) and "Alemtuzumab 12 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Louisville Research Foundation" are 17 trials for "All" genders.

Currently, there are NaN active trials in "University of Louisville Research Foundation". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in University of Louisville Research Foundation, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in University of Louisville Research Foundation, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".